Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 103

1.

Risk-based selection from the general population in a screening trial: selection criteria, recruitment and power for the Dutch-Belgian randomised lung cancer multi-slice CT screening trial (NELSON).

van Iersel CA, de Koning HJ, Draisma G, Mali WP, Scholten ET, Nackaerts K, Prokop M, Habbema JD, Oudkerk M, van Klaveren RJ.

Int J Cancer. 2007 Feb 15;120(4):868-74.

2.

Occurrence and lung cancer probability of new solid nodules at incidence screening with low-dose CT: analysis of data from the randomised, controlled NELSON trial.

Walter JE, Heuvelmans MA, de Jong PA, Vliegenthart R, van Ooijen PMA, Peters RB, Ten Haaf K, Yousaf-Khan U, van der Aalst CM, de Bock GH, Mali W, Groen HJM, de Koning HJ, Oudkerk M.

Lancet Oncol. 2016 Jul;17(7):907-916. doi: 10.1016/S1470-2045(16)30069-9. Epub 2016 Jun 6.

PMID:
27283862
3.

Generalisability of the results of the Dutch-Belgian randomised controlled lung cancer CT screening trial (NELSON): does self-selection play a role?

van der Aalst CM, van Iersel CA, van Klaveren RJ, Frenken FJ, Fracheboud J, Otto SJ, de Jong PA, Oudkerk M, de Koning HJ.

Lung Cancer. 2012 Jul;77(1):51-7. doi: 10.1016/j.lungcan.2012.02.021. Epub 2012 Mar 27.

PMID:
22459203
4.

Limited contamination in the Dutch-Belgian randomized lung cancer screening trial (NELSON).

Baecke E, de Koning HJ, Otto SJ, van Iersel CA, van Klaveren RJ.

Lung Cancer. 2010 Jul;69(1):66-70. doi: 10.1016/j.lungcan.2009.08.015. Epub 2009 Oct 3.

PMID:
19801174
5.

Detection of lung cancer through low-dose CT screening (NELSON): a prespecified analysis of screening test performance and interval cancers.

Horeweg N, Scholten ET, de Jong PA, van der Aalst CM, Weenink C, Lammers JW, Nackaerts K, Vliegenthart R, ten Haaf K, Yousaf-Khan UA, Heuvelmans MA, Thunnissen E, Oudkerk M, Mali W, de Koning HJ.

Lancet Oncol. 2014 Nov;15(12):1342-50. doi: 10.1016/S1470-2045(14)70387-0. Epub 2014 Oct 1.

PMID:
25282284
6.

Nodule management protocol of the NELSON randomised lung cancer screening trial.

Xu DM, Gietema H, de Koning H, Vernhout R, Nackaerts K, Prokop M, Weenink C, Lammers JW, Groen H, Oudkerk M, van Klaveren R.

Lung Cancer. 2006 Nov;54(2):177-84. Epub 2006 Sep 20.

PMID:
16989922
7.

Baseline Characteristics and Mortality Outcomes of Control Group Participants and Eligible Non-Responders in the NELSON Lung Cancer Screening Study.

Yousaf-Khan U, Horeweg N, van der Aalst C, Ten Haaf K, Oudkerk M, de Koning H.

J Thorac Oncol. 2015 May;10(5):747-53. doi: 10.1097/JTO.0000000000000488.

8.

Risk stratification based on screening history: the NELSON lung cancer screening study.

Yousaf-Khan U, van der Aalst C, de Jong PA, Heuvelmans M, Scholten E, Walter J, Nackaerts K, Groen H, Vliegenthart R, Ten Haaf K, Oudkerk M, de Koning H.

Thorax. 2017 Sep;72(9):819-824. doi: 10.1136/thoraxjnl-2016-209892. Epub 2017 Mar 30.

PMID:
28360223
9.

Lung cancer probability in patients with CT-detected pulmonary nodules: a prespecified analysis of data from the NELSON trial of low-dose CT screening.

Horeweg N, van Rosmalen J, Heuvelmans MA, van der Aalst CM, Vliegenthart R, Scholten ET, ten Haaf K, Nackaerts K, Lammers JW, Weenink C, Groen HJ, van Ooijen P, de Jong PA, de Bock GH, Mali W, de Koning HJ, Oudkerk M.

Lancet Oncol. 2014 Nov;15(12):1332-41. doi: 10.1016/S1470-2045(14)70389-4. Epub 2014 Oct 1.

PMID:
25282285
10.

Lung cancer screening and smoking abstinence: 2 year follow-up data from the Dutch-Belgian randomised controlled lung cancer screening trial.

van der Aalst CM, van den Bergh KA, Willemsen MC, de Koning HJ, van Klaveren RJ.

Thorax. 2010 Jul;65(7):600-5. doi: 10.1136/thx.2009.133751.

PMID:
20627916
11.

The UK Lung Cancer Screening Trial: a pilot randomised controlled trial of low-dose computed tomography screening for the early detection of lung cancer.

Field JK, Duffy SW, Baldwin DR, Brain KE, Devaraj A, Eisen T, Green BA, Holemans JA, Kavanagh T, Kerr KM, Ledson M, Lifford KJ, McRonald FE, Nair A, Page RD, Parmar MK, Rintoul RC, Screaton N, Wald NJ, Weller D, Whynes DK, Williamson PR, Yadegarfar G, Hansell DM.

Health Technol Assess. 2016 May;20(40):1-146. doi: 10.3310/hta20400.

12.

Biochemical verification of the self-reported smoking status of screened male smokers of the Dutch-Belgian randomized controlled lung cancer screening trial.

van der Aalst CM, de Koning HJ.

Lung Cancer. 2016 Apr;94:96-101. doi: 10.1016/j.lungcan.2016.02.001. Epub 2016 Feb 4.

PMID:
26973213
13.

Long-term effects of lung cancer computed tomography screening on health-related quality of life: the NELSON trial.

van den Bergh KA, Essink-Bot ML, Borsboom GJ, Scholten ET, van Klaveren RJ, de Koning HJ.

Eur Respir J. 2011 Jul;38(1):154-61. doi: 10.1183/09031936.00123410. Epub 2010 Dec 9.

14.

Characteristics of lung cancers detected by computer tomography screening in the randomized NELSON trial.

Horeweg N, van der Aalst CM, Thunnissen E, Nackaerts K, Weenink C, Groen HJ, Lammers JW, Aerts JG, Scholten ET, van Rosmalen J, Mali W, Oudkerk M, de Koning HJ.

Am J Respir Crit Care Med. 2013 Apr 15;187(8):848-54. doi: 10.1164/rccm.201209-1651OC.

PMID:
23348977
15.

NELSON lung cancer screening study.

Ru Zhao Y, Xie X, de Koning HJ, Mali WP, Vliegenthart R, Oudkerk M.

Cancer Imaging. 2011 Oct 3;11 Spec No A:S79-84. doi: 10.1102/1470-7330.2011.9020.

16.

Design, recruitment and baseline results of the ITALUNG trial for lung cancer screening with low-dose CT.

Lopes Pegna A, Picozzi G, Mascalchi M, Maria Carozzi F, Carrozzi L, Comin C, Spinelli C, Falaschi F, Grazzini M, Innocenti F, Ronchi C, Paci E; ITALUNG Study Research Group.

Lung Cancer. 2009 Apr;64(1):34-40. doi: 10.1016/j.lungcan.2008.07.003. Epub 2008 Aug 23.

PMID:
18723240
17.

Final screening round of the NELSON lung cancer screening trial: the effect of a 2.5-year screening interval.

Yousaf-Khan U, van der Aalst C, de Jong PA, Heuvelmans M, Scholten E, Lammers JW, van Ooijen P, Nackaerts K, Weenink C, Groen H, Vliegenthart R, Ten Haaf K, Oudkerk M, de Koning H.

Thorax. 2017 Jan;72(1):48-56. doi: 10.1136/thoraxjnl-2016-208655. Epub 2016 Jun 30.

PMID:
27364640
18.

Pulmonary perifissural nodules on CT scans: rapid growth is not a predictor of malignancy.

de Hoop B, van Ginneken B, Gietema H, Prokop M.

Radiology. 2012 Nov;265(2):611-6. doi: 10.1148/radiol.12112351. Epub 2012 Aug 28.

PMID:
22929331
19.

Screening for lung cancer by imaging: the Nelson study.

Oudkerk M, Heuvelmans MA.

JBR-BTR. 2013 May-Jun;96(3):163-6.

PMID:
23971173
20.

Short-term health-related quality of life consequences in a lung cancer CT screening trial (NELSON).

van den Bergh KA, Essink-Bot ML, Borsboom GJ, Th Scholten E, Prokop M, de Koning HJ, van Klaveren RJ.

Br J Cancer. 2010 Jan 5;102(1):27-34. doi: 10.1038/sj.bjc.6605459. Epub 2009 Nov 24.

Supplemental Content

Support Center